Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases

Nature Communications

Volumn 5, Issue , 2014, Pages

  Charles, Joël P ^a   Fuchs, Jeannette ^a   Hefter, Mirjam ^a   Vischedyk, Jonas B ^a   Kleint, Maximilian ^a   Vogiatzi, Fotini ^a   Schäfer, Jonas A ^a   Nist, Andrea ^a   Timofeev, Oleg ^a   Wanzel, Michael ^a   Stiewe, Thorsten ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYPRIDINA NOCTILUCA LUCIFERASE; DOXYCYCLINE; GAUSSIA PRINCEPS LUCIFERASE; LENTIVIRUS VECTOR; LUCIFERASE; NUTLIN 3; POLO LIKE KINASE 1; PROTEIN MDM2; PROTEIN P53; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; SMALL INTERFERING RNA;

BIOMONITORING; CELL ORGANELLE; DEVELOPMENTAL BIOLOGY; ENZYME ACTIVITY; GENETIC ANALYSIS; NUMERICAL MODEL; SECRETION; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; BLOOD FLOW; CELL POPULATION; CELL PROLIFERATION; CLONAL EVOLUTION; CLONE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; FEMALE; GENETIC MANIPULATION; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH; ANIMAL; FLUORESCENCE MICROSCOPY; GENE VECTOR; GENETICS; HCT116 CELL LINE; HUMAN; IN VITRO STUDY; METABOLISM; NEOPLASM; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CLONAL EVOLUTION; GENETIC VECTORS; HCT116 CELLS; HUMANS; IN VITRO TECHNIQUES; LUCIFERASES; MICE; MICROSCOPY, FLUORESCENCE; NEOPLASMS; RNA, SMALL INTERFERING;

EID: 84901950456     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4981     Document Type: Article

References (34)

1. Cairns, J. Mutation selection and the natural history of cancer. Nature 255, 197-200 (1975).
2. Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23-28 (1976).
3. Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306-313 (2012).
4. Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338-345 (2013).
5. Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature 501, 328-337 (2013).
6. Bedard, P. L., Hansen, A. R., Ratain, M. J. & Siu, L. L. Tumour heterogeneity in the clinic. Nature 501, 355-364 (2013).
7. Klein, C. A. Selection and adaptation during metastatic cancer progression. Nature 501, 365-372 (2013).
8. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
9. Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339 (2014).
10. Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002). (Pubitemid 34408678)
11. Bernards, R., Brummelkamp, T. R. & Beijersbergen, R. L. shRNA libraries and their use in cancer genetics. Nat Meth 3, 701-706 (2006). (Pubitemid 44275737)
12. Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346-350 (2011).
13. Zuber, J. et al. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat. Biotechnol. 29, 79-83 (2011).
14. Zuber, J. et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524-528 (2011).
15. Beitzinger, M. et al. p73 poses a barrier to malignant transformation by limiting anchorage-independent growth. EMBO J. 27, 792-803 (2008). (Pubitemid 351506677)
16. Smogorzewska, A. et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129, 289-301 (2007). (Pubitemid 46584733)
17. Dickins, R. A. et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37, 1289-1295 (2005). (Pubitemid 41568715)
18. Weissleder, R. & Ntziachristos, V. Shedding light onto live molecular targets. Nat. Med. 9, 123-128 (2003). (Pubitemid 36098273)
19. Dawson, S.-J. et al. Analysis of circulating tumor dna to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199-1209 (2013).
20. Mouliere, F. et al. Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load. Transl. Oncol. 6, 319-328 (2013).
21. Thierry, A. R. et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic. Acids. Res. 38, 6159-6175 (2010).
22. Tannous, B. A. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat. Protoc. 4, 582-591 (2009).
23. Wurdinger, T. et al. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat. Methods 5, 171-173 (2008). (Pubitemid 351181745)
24. Chung, E. et al. Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PLoS ONE 4, e8316 (2009).
25. Nakajima, Y., Kobayashi, K., Yamagishi, K., Enomoto, T. & Ohmiya, Y. cDNA cloning and characterization of a secreted luciferase from the luminous Japanese ostracod, Cypridina noctiluca. Biosci. Biotechnol. Biochem. 68, 565-570 (2004). (Pubitemid 39251493)
26. Stegmeier, F., Hu, G., Rickles, R. J., Hannon, G. J. & Elledge, S. J. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl Acad. Sci. USA 102, 13212-13217 (2005). (Pubitemid 41325003)
27. Vousden, K. H. & Lane, D. P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283 (2007). (Pubitemid 46474662)
28. Adorno, M. et al. A mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 137, 87-98 (2009).
29. Schlabach, M. R. et al. Cancer proliferation gene discovery through functional genomics. Science 319, 620-624 (2008). (Pubitemid 351197064)
30. Meerbrey, K. L. et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc. Natl Acad. Sci. USA 108, 3665-3670 (2011).
31. Darne, C., Lu, Y. & Sevick-Muraca, E. M. Small animal fluorescence and bioluminescence tomography: a review of approaches, algorithms and technology update. Phys. Med. Biol. 59, R1-R64 (2013).
32. Russell, W. M. S. & Burch, R. L. The Principles of Humane Experimental Technique (Methuen & Co., 1959).
33. Close, D. M., Xu, T., Sayler, G. S. & Ripp, S. In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals. Sensors (Basel) 11, 180-206 (2011).
34. Kutner, R. H., Zhang, X.-Y. & Reiser, J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 4, 495-505 (2009).